Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Erskine D, Taylor JP, Thomas A, Collerton D, McKeith I, Khundakar A, Attems J, Morris C.

Neurosci Bull. 2019 Feb 6. doi: 10.1007/s12264-019-00341-4. [Epub ahead of print] No abstract available.

PMID:
30729454
2.

Dementia with Lewy bodies: an update and outlook.

Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor JP, Thomas A, Attems J, McKeith I.

Mol Neurodegener. 2019 Jan 21;14(1):5. doi: 10.1186/s13024-019-0306-8. Review.

3.

Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial.

Elder GJ, Colloby SJ, Firbank MJ, McKeith IG, Taylor JP.

Alzheimers Res Ther. 2019 Jan 18;11(1):9. doi: 10.1186/s13195-018-0465-9.

4.

Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.

McAleese KE, Graham S, Dey M, Walker L, Erskine D, Johnson M, Johnston E, Thomas AJ, McKeith IG, DeCarli C, Attems J.

Brain Pathol. 2018 Nov 28. doi: 10.1111/bpa.12685. [Epub ahead of print]

PMID:
30485582
5.

Levodopa may affect cortical excitability in Parkinson's disease patients with cognitive deficits as revealed by reduced activity of cortical sources of resting state electroencephalographic rhythms.

Babiloni C, Del Percio C, Lizio R, Noce G, Lopez S, Soricelli A, Ferri R, Pascarelli MT, Catania V, Nobili F, Arnaldi D, Famà F, Orzi F, Buttinelli C, Giubilei F, Bonanni L, Franciotti R, Onofrj M, Stirpe P, Fuhr P, Gschwandtner U, Ransmayr G, Fraioli L, Parnetti L, Farotti L, Pievani M, D'Antonio F, De Lena C, Güntekin B, Hanoğlu L, Yener G, Emek-Savaş DD, Triggiani AI, Taylor JP, McKeith I, Stocchi F, Vacca L, Frisoni GB, De Pandis MF.

Neurobiol Aging. 2019 Jan;73:9-20. doi: 10.1016/j.neurobiolaging.2018.08.010. Epub 2018 Aug 30.

PMID:
30312790
6.

The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target.

Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, Zhu K, Wang S, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, Navarro L, De Jager P, Schneider JA, Morris CM, McKeith IG, Perry RH, Lovestone S, Woltjer RL, Beach TG, Sue LI, Serrano GE, Lieberman AP, Albin RL, Ferrer I, Mash DC, Hulette CM, Ervin JF, Reiman EM, Hardy JA, Bennett DA, Schadt E, Smith RD, Myers AJ.

Brain. 2018 Sep 1;141(9):2721-2739. doi: 10.1093/brain/awy215.

7.

Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study.

Thomas AJ, Taylor JP, McKeith I, Bamford C, Burn D, Allan L, O'Brien J.

Int J Geriatr Psychiatry. 2018 Oct;33(10):1293-1304. doi: 10.1002/gps.4948. Epub 2018 Aug 9. No abstract available.

8.

Diagnostic accuracy of dopaminergic imaging in prodromal dementia with Lewy bodies.

Thomas AJ, Donaghy P, Roberts G, Colloby SJ, Barnett NA, Petrides G, Lloyd J, Olsen K, Taylor JP, McKeith I, O'Brien JT.

Psychol Med. 2019 Feb;49(3):396-402. doi: 10.1017/S0033291718000995. Epub 2018 Apr 25.

9.

Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies.

Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM.

Mov Disord. 2018 Jul;33(6):982-991. doi: 10.1002/mds.27333. Epub 2018 Mar 23.

PMID:
29570843
10.

Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.

Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP.

Mov Disord. 2018 Apr;33(4):503-510. doi: 10.1002/mds.27323. Epub 2018 Feb 28. Review.

PMID:
29488270
11.

Clinical prevalence of Lewy body dementia.

Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O'Brien JT.

Alzheimers Res Ther. 2018 Feb 15;10(1):19. doi: 10.1186/s13195-018-0350-6.

12.

Author response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG.

Neurology. 2018 Feb 6;90(6):300-301. doi: 10.1212/WNL.0000000000004919. No abstract available.

PMID:
29438029
13.

Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.

Donaghy PC, Taylor JP, O'Brien JT, Barnett N, Olsen K, Colloby SJ, Lloyd J, Petrides G, McKeith IG, Thomas AJ.

Psychol Med. 2018 Oct;48(14):2384-2390. doi: 10.1017/S0033291717003956. Epub 2018 Jan 24.

PMID:
29362011
14.

Non-pharmacological interventions for Lewy body dementia: a systematic review.

Connors MH, Quinto L, McKeith I, Brodaty H, Allan L, Bamford C, Thomas A, Taylor JP, O'Brien JT.

Psychol Med. 2018 Aug;48(11):1749-1758. doi: 10.1017/S0033291717003257. Epub 2017 Nov 16.

15.

Regional levels of physiological α-synuclein are directly associated with Lewy body pathology.

Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, Morris CM.

Acta Neuropathol. 2018 Jan;135(1):153-154. doi: 10.1007/s00401-017-1787-6. Epub 2017 Nov 13. No abstract available.

PMID:
29134319
16.

Author response: Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.

Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z.

Neurology. 2017 Aug 15;89(7):751. doi: 10.1212/WNL.0000000000004254. No abstract available.

PMID:
28808169
17.

Transcranial direct current stimulation in Parkinson's disease dementia: A randomised double-blind crossover trial.

Elder GJ, Ashcroft J, da Silva Morgan K, Umme Kulsum M, Banerjee R, Chatterjee P, Firbank MJ, McKeith IG, Kumar H, Taylor JP.

Brain Stimul. 2017 Nov - Dec;10(6):1150-1151. doi: 10.1016/j.brs.2017.07.012. Epub 2017 Jul 31. No abstract available.

PMID:
28802804
18.

Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.

McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J.

Acta Neuropathol. 2017 Sep;134(3):459-473. doi: 10.1007/s00401-017-1738-2. Epub 2017 Jun 21.

19.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

20.

Symptoms associated with Lewy body disease in mild cognitive impairment.

Donaghy PC, Barnett N, Olsen K, Taylor JP, McKeith IG, O'Brien JT, Thomas AJ.

Int J Geriatr Psychiatry. 2017 Nov;32(11):1163-1171. doi: 10.1002/gps.4742. Epub 2017 May 29.

PMID:
28556415
21.

Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort.

Kramberger MG, Auestad B, Garcia-Ptacek S, Abdelnour C, Olmo JG, Walker Z, Lemstra AW, Londos E, Blanc F, Bonanni L, McKeith I, Winblad B, de Jong FJ, Nobili F, Stefanova E, Petrova M, Falup-Pecurariu C, Rektorova I, Bostantjopoulou S, Biundo R, Weintraub D, Aarsland D; E-DLB.

J Alzheimers Dis. 2017;57(3):787-795. doi: 10.3233/JAD-161109.

22.

Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts.

Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J.

J Neural Transm (Vienna). 2017 Jun;124(6):671-683. doi: 10.1007/s00702-017-1702-2. Epub 2017 Mar 6.

23.

Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA.

Am J Geriatr Psychiatry. 2017 Jun;25(6):595-604. doi: 10.1016/j.jagp.2017.01.005. Epub 2017 Jan 10.

PMID:
28190674
24.

Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.

O'Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I, Mittler P, Passmore P, Ritchie C, Robinson L, Sampson EL, Taylor JP, Thomas A, Burns A.

J Psychopharmacol. 2017 Feb;31(2):147-168. doi: 10.1177/0269881116680924. Epub 2017 Jan 20. Review.

PMID:
28103749
25.

Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies.

Erskine D, Thomas AJ, Attems J, Taylor JP, McKeith IG, Morris CM, Khundakar AA.

Mov Disord. 2017 Mar;32(3):414-422. doi: 10.1002/mds.26887. Epub 2017 Jan 6.

PMID:
28059471
26.

Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB.

Thomas AJ, Attems J, Colloby SJ, O'Brien JT, McKeith I, Walker R, Lee L, Burn D, Lett DJ, Walker Z.

Neurology. 2017 Jan 17;88(3):276-283. doi: 10.1212/WNL.0000000000003512. Epub 2016 Dec 9.

27.

Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study.

Thomas AJ, Taylor JP, McKeith I, Bamford C, Burn D, Allan L, O'Brien J.

Int J Geriatr Psychiatry. 2017 Dec;32(12):1280-1304. doi: 10.1002/gps.4609. Epub 2016 Dec 8.

28.

Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.

Cummings J, Scheltens P, McKeith I, Blesa R, Harrison JE, Bertolucci PH, Rockwood K, Wilkinson D, Wijker W, Bennett DA, Shah RC.

J Alzheimers Dis. 2017;55(3):1131-1139.

29.

Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial).

Knapp M, King D, Romeo R, Adams J, Baldwin A, Ballard C, Banerjee S, Barber R, Bentham P, Brown RG, Burns A, Dening T, Findlay D, Holmes C, Johnson T, Jones R, Katona C, Lindesay J, Macharouthu A, McKeith I, McShane R, O'Brien JT, Phillips PPJ, Sheehan B, Howard R.

Int J Geriatr Psychiatry. 2017 Dec;32(12):1205-1216. doi: 10.1002/gps.4583. Epub 2016 Oct 13.

30.

Revisiting DLB Diagnosis: A Consideration of Prodromal DLB and of the Diagnostic Overlap With Alzheimer Disease.

McKeith I, Taylor JP, Thomas A, Donaghy P, Kane J.

J Geriatr Psychiatry Neurol. 2016 Sep;29(5):249-53. doi: 10.1177/0891988716656083.

PMID:
27502299
31.

TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.

McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J.

Brain Pathol. 2017 Jul;27(4):472-479. doi: 10.1111/bpa.12424. Epub 2016 Aug 24.

PMID:
27495267
32.

Arguing against the proposed definition changes of PD.

Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP.

Mov Disord. 2016 Nov;31(11):1619-1622. doi: 10.1002/mds.26721. Epub 2016 Aug 5. Review.

33.

Grey matter atrophy in prodromal stage of dementia with Lewy bodies and Alzheimer's disease.

Blanc F, Colloby SJ, Cretin B, de Sousa PL, Demuynck C, O'Brien JT, Martin-Hunyadi C, McKeith I, Philippi N, Taylor JP.

Alzheimers Res Ther. 2016 Jul 20;8:31. doi: 10.1186/s13195-016-0198-6.

34.

Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations.

Khundakar AA, Hanson PS, Erskine D, Lax NZ, Roscamp J, Karyka E, Tsefou E, Singh P, Cockell SJ, Gribben A, Ramsay L, Blain PG, Mosimann UP, Lett DJ, Elstner M, Turnbull DM, Xiang CC, Brownstein MJ, O'Brien JT, Taylor JP, Attems J, Thomas AJ, McKeith IG, Morris CM.

Acta Neuropathol Commun. 2016 Jun 30;4(1):66. doi: 10.1186/s40478-016-0334-3.

35.

Cholinergic and perfusion brain networks in Parkinson disease dementia.

Colloby SJ, McKeith IG, Burn DJ, Wyper DJ, O'Brien JT, Taylor JP.

Neurology. 2016 Jul 12;87(2):178-85. doi: 10.1212/WNL.0000000000002839. Epub 2016 Jun 15.

36.

Exome sequencing in dementia with Lewy bodies.

Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, Chinnery PF.

Transl Psychiatry. 2016 Feb 2;6:e728. doi: 10.1038/tp.2015.220.

37.

Visual Hallucinations in Eye Disease and Lewy Body Disease.

Urwyler P, Nef T, Müri R, Archibald N, Makin SM, Collerton D, Taylor JP, Burn D, McKeith I, Mosimann UP.

Am J Geriatr Psychiatry. 2016 May;24(5):350-8. doi: 10.1016/j.jagp.2015.10.007. Epub 2015 Oct 21.

PMID:
26796926
38.

Depressive symptoms are associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies.

Elder GJ, Colloby SJ, Lett DJ, O'Brien JT, Anderson KN, Burn DJ, McKeith IG, Taylor JP.

Int J Geriatr Psychiatry. 2016 Jul;31(7):765-70. doi: 10.1002/gps.4389. Epub 2015 Nov 11.

39.

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.

Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, Burns A, Dening T, Findlay D, Holmes C, Jones R, Jones R, McKeith I, Macharouthu A, O'Brien J, Sheehan B, Juszczak E, Katona C, Hills R, Knapp M, Ballard C, Brown RG, Banerjee S, Adams J, Johnson T, Bentham P, Phillips PP.

Lancet Neurol. 2015 Dec;14(12):1171-81. doi: 10.1016/S1474-4422(15)00258-6. Epub 2015 Oct 27.

PMID:
26515660
40.

Support and information needs following a diagnosis of dementia with Lewy bodies.

Killen A, Flynn D, De Brún A, O'Brien N, O'Brien J, Thomas AJ, McKeith I, Taylor JP.

Int Psychogeriatr. 2016 Mar;28(3):495-501. doi: 10.1017/S1041610215001362. Epub 2015 Sep 2.

PMID:
26328546
41.

Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences.

Peraza LR, Colloby SJ, Firbank MJ, Greasy GS, McKeith IG, Kaiser M, O'Brien J, Taylor JP.

Int J Geriatr Psychiatry. 2015 Nov;30(11):1135-46. doi: 10.1002/gps.4342. Epub 2015 Aug 13.

42.

Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.

Colloby SJ, McKeith IG, Wyper DJ, O'Brien JT, Taylor JP.

J Neurol. 2015 Sep;262(9):2144-53. doi: 10.1007/s00415-015-7827-z. Epub 2015 Jun 30.

PMID:
26122542
43.

Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.

Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, Mak E, Cambridge V, Mason J, Thomas A, O'Brien JT.

Am J Psychiatry. 2015 Aug 1;172(8):731-42. doi: 10.1176/appi.ajp.2015.14121582. Epub 2015 Jun 18. Review.

PMID:
26085043
44.

Cortical Thickness in Dementia with Lewy Bodies and Alzheimer's Disease: A Comparison of Prodromal and Dementia Stages.

Blanc F, Colloby SJ, Philippi N, de Pétigny X, Jung B, Demuynck C, Phillipps C, Anthony P, Thomas A, Bing F, Lamy J, Martin-Hunyadi C, O'Brien JT, Cretin B, McKeith I, Armspach JP, Taylor JP.

PLoS One. 2015 Jun 10;10(6):e0127396. doi: 10.1371/journal.pone.0127396. eCollection 2015.

45.

Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies.

Erskine D, Taylor JP, Firbank MJ, Patterson L, Onofrj M, O'Brien JT, McKeith IG, Attems J, Thomas AJ, Morris CM, Khundakar AA.

Neuropathol Appl Neurobiol. 2016 Jun;42(4):366-76. doi: 10.1111/nan.12249. Epub 2015 Jun 2.

46.

Patient and Informant Views on Visual Hallucinations in Parkinson Disease.

Urwyler P, Nef T, Müri RM, Killen A, Collerton D, Burn D, McKeith I, Mosimann UP.

Am J Geriatr Psychiatry. 2015 Sep;23(9):970-6. doi: 10.1016/j.jagp.2014.12.190. Epub 2014 Dec 30.

PMID:
25623941
47.

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load.

Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG.

Neurology. 2015 Feb 3;84(5):496-9. doi: 10.1212/WNL.0000000000001204. Epub 2014 Dec 31.

48.

The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.

Donaghy PC, McKeith IG.

Alzheimers Res Ther. 2014 Jul 21;6(4):46. doi: 10.1186/alzrt274. eCollection 2014. Review.

49.

Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.

Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, Masuda-Suzukake M, Hasegawa M, Rollinson S, Pickering-Brown S, Robinson AC, Davidson YS, Mann DM.

Neuropathol Appl Neurobiol. 2015 Aug;41(5):601-12. doi: 10.1111/nan.12178. Epub 2015 Apr 30.

50.

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.

O'Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K, Tolosa E, Sherwin PF, Grachev ID.

BMJ Open. 2014 Jul 3;4(7):e005122. doi: 10.1136/bmjopen-2014-005122.

Supplemental Content

Loading ...
Support Center